The Priority Review

Tag

Crovalimab

1 story

  1. Clinical trials

    Hoffmann-La Roche posts results of Phase III crovalimab study in aHUS

    Results for the Phase III, single-arm study of crovalimab in adult and adolescent patients with atypical hemolytic uremic syndrome were first posted on ClinicalTrials.gov on October 30, 2026, after enrolling 83 participants. The study, which began on October 22, 2021, reached primary completion on October 9, 2025.